Literatur
-
1
Naginton J, Watson P G, Playfair T J et al.
Amoebic infection of the eye.
Lancet.
1974;
2
1537-1540
-
2
Jones D B, Visvesvara G S, Robinson N M.
Acanthamoeba polyphaga keratitis and Acenthamoeba uveitis associated with fatal meningoencephalitis.
Trans Ophthalmol Soc UK.
1975;
95
221-232
-
3
Ku J Y, Chan F M, Beckingsale P.
Acanthamoeba keratitis cluster: an increase in Acanthamoeba keratitis in Australia.
Clin Experiment Ophthalmol.
2009;
37
181-190
-
4
Moore M B, McCulley J P, Newton C et al.
Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers.
Ophthalmology.
1987;
94
1654-1661
-
5
Schaumberg D A, Snow K K, Dana M R.
The epidemic of Acanthamoeba keratitis: where do we stand?.
Cornea.
1998;
17
3-10
-
6
Butler T K, Males J J, Robinson L P et al.
Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997–2002.
Clin Experiment Ophthalmol.
2005;
33
41-46
-
7
Acharya N R, Lietman T M, Margolis T P.
Parasites on the rise: a new epidemic of Acanthamoeba keratitis.
Am J Ophthalmol.
2007;
144
292-293
-
8 Pschyrembel. Klinisches Wörterbuch.. 259. Aufl. Berlin: de Gruyter; 2002
-
9
Marciano-Cabral F, Cabral G.
Acanthamoeba spp. as agents of disease in humans.
Clin Microbiol Rev.
2003;
16
273-307
-
10
Pussard M, Pons R.
Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida).
Protistologica.
1977;
13
557-610
-
11
Stothard D R, Hay J, Schroeder-Diedrich J M et al.
Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type.
J Clin Microbiol.
1999;
37
2687-2693
-
12
Walochnik J, Haller-Schober E, Kolli H et al.
Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens wearing keratitis patients in Austria.
J Clin Microbiol.
2000;
38
3932-3936
-
13
Stothard D R, Schroeder-Diedrich J M, Awwad M H et al.
The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types.
J Eukaryot Microbiol.
1998;
45
45-54
-
14
Weekers P H, Bodelier P L, Wijen J P et al.
Effects of grazing by the free-living soil amoebae Acanthamoeba castellanii, Acanthamoeba polyphaga, and Hartmannella vermiformis on various bacteria.
Appl Environ Microbiol.
1993;
59
2317-2319
-
15
Chagla A H, Griffiths A J.
Growth and encystation of Acanthamoeba castellanii.
J Gen Microbiol.
1974;
85
139-145
-
16
De Jonckheere J, van de Voorde H.
Differences in destruction of cysts of pathogenic and nonpathogenic Naegleria and Acanthamoeba by chlorine.
Appl Environ Microbiol.
1976;
31
294-297
-
17
Khunkitti W, Lloyd D, Furr J R et al.
Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility.
J Infect.
1998;
36
43-48
-
18
Brown T J, Cursons R T.
Pathogenic free-living amebae (PFLA) from frozen swimming areas in Oslo, Norway.
Scand J Infect Dis.
1977;
9
237-240
-
19
Aksozek A, McClellan K, Howard K et al.
Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions.
J Parasitol.
2002;
88
621-623
-
20
Mazur T, Hadas E, Iwanicka I.
The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates.
Trop Med Parasitol.
1995;
46
106-108
-
21
Michel R, Burghardt H, Bergmann H.
Acanthamoeba, naturally intracellularly infected with Pseudomonas aeruginosa, after their isolation from a microbiologically contaminated drinking water system in a hospital.
Zentralbl Hyg Umweltmed.
1995;
196
532-544
-
22
Barker J, Scaife H, Brown M R.
Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila.
Antimicrob Agents Chemother.
1995;
39
2684-2688
-
23
Seal D V.
Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment.
Eye (Lond).
2003;
17
893-905
-
24
Dart J K, Saw V P, Kilvington S.
Acanthamoeba keratitis: diagnosis and treatment update 2009.
Am J Ophthalmol.
2009;
148
487-499
-
25
Tu E Y, Joslin C E.
Recent outbreaks of atypical contact lens-related keratitis: what have we learned?.
Am J Ophthalmol.
2010;
150
602-608
-
26
Foulks G N.
Acanthamoeba keratitis and contact lens wear: static or increasing problem?.
Eye Contact Lens.
2007;
33
412-414
discussion 414-415
-
27
Bacon A S, Frazer D G, Dart J K et al.
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992.
Eye (Lond).
1993;
7 (Pt 6)
719-725
-
28
Carvalho F R, Foronda A S, Mannis M J et al.
Twenty years of Acanthamoeba keratitis.
Cornea.
2009;
28
516-519
-
29
McAllum P, Bahar I, Kaiserman I et al.
Temporal and seasonal trends in Acanthamoeba keratitis.
Cornea.
2009;
28
7-10
-
30
Radford C F, Lehmann O J, Dart J K. National Acanthamoeba Keratitis Study Group .
Acanthamoeba keratitis: multicentre survey in England 1992–6.
Br J Ophthalmol.
1998;
82
1387-1392
-
31
Chew H F, Yildiz E H, Hammersmith K M et al.
Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis.
Cornea.
2010;
epub ahead of print
-
32
Centers for Disease Control and Prevention (CDC) .
Acanthamoeba keratitis multiple states, 2005–2007.
MMWR Morb Mortal Wkly Rep.
2007;
56
532-534
-
33
Johnston S P, Sriram R, Qvarnstrom Y et al.
Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.
J Clin Microbiol.
2009;
47
2040-2045
-
34
Hammersmith K M.
Diagnosis and management of Acanthamoeba keratitis.
Curr Opin Ophthalmol.
2006;
17
327-331
-
35
Watt K, Swarbrick H A.
Microbial keratitis in overnight orthokeratology: review of the first 50 cases.
Eye Contact Lens.
2005;
31
201-208
-
36
Stehr-Green J K, Bailey T M, Visvesvara G S.
The epidemiology of Acanthamoeba keratitis in the United States.
Am J Ophthalmol.
1989;
107
331-336
-
37
Radford C F, Minassian D C, Dart J K.
Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors.
Br J Ophthalmol.
2002;
86
536-542
-
38
Sharma S, Garg P, Rao G N.
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis.
Br J Ophthalmol.
2000;
84
1103-1108
-
39
Camposampiero D, Caramello G, Indemini P et al.
Two red eyes and one asymptomatic donor.
Lancet.
2009;
374
1792
-
40
Panjwani N.
Pathogenesis of Acanthamoeba keratitis.
Ocul Surf.
2010;
8
70-79
-
41
Clarke D W, Niederkorn J Y.
The pathophysiology of Acanthamoeba keratitis.
Trends Parasitol.
2006;
22
175-180
-
42
van Klink F, Alizadeh H, He Y et al.
The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis.
Invest Ophthalmol Vis Sci.
1993;
34
1937-1944
-
43
Hadas E, Mazur T.
Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp.
Trop Med Parasitol.
1993;
44
197-200
-
44
Clarke D W, Alizadeh H, Niederkorn J Y.
Failure of Acanthamoeba castellanii to produce intraocular infections.
Invest Ophthalmol Vis Sci.
2005;
46
2472-2478
-
45
Niederkorn J Y, Alizadeh H, Leher H F et al.
The immunobiology of Acanthamoeba keratitis.
Springer Semin Immunopathol.
1999;
21
147-160
-
46
Sun X, Zhang Y, Li R et al.
Acanthamoeba keratitis: clinical characteristics and management.
Ophthalmology.
2006;
113
412-416
-
47
Claerhout I, Goegebuer A, Van Den Broecke C et al.
Delay in diagnosis and outcome of Acanthamoeba keratitis.
Graefes Arch Clin Exp Ophthalmol.
2004;
242
648-653
-
48
Reinhard T, Behrens-Baumann W.
Anti-infective drug therapy in ophthalmology – part 4: Acanthamoeba keratitis.
Klin Monbl Augenheilkd.
2006;
223
485-492
-
49
Stemberger K, Dick B, Kramann C et al.
Painless Acanthamoeba keratitis.
Ophthalmologe.
2007;
104
415-417
-
50
Wilhelmus K R, Jones D B, Matoba A Y et al.
Bilateral Acanthamoeba keratitis.
Am J Ophthalmol.
2008;
145
193-197
-
51
Perry H D, Donnenfeld E D, Foulks G N et al.
Decreased corneal sensation as an initial feature of Acanthamoeba keratitis.
Ophthalmology.
1995;
102
1565-1568
-
52
Awwad S T, Petroll W M, McCulley J P et al.
Updates in Acanthamoeba keratitis.
Eye Contact Lens.
2007;
33
1-8
-
53
Patel D V, McGhee C N.
Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs.
Clin Experiment Ophthalmol.
2009;
37
232-238
-
54
Nakano E, Oliveira M, Portellinha W et al.
Confocal microscopy in early diagnosis of Acanthamoeba keratitis.
J Refract Surg.
2004;
20
S737-740
-
55
Illingworth C D, Cook S D, Karabatsas C H et al.
Acanthamoeba keratitis: risk factors and outcome.
Br J Ophthalmol.
1995;
79
1078-1082
-
56
Moore M B, McCulley J P, Kaufman H E et al.
Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis.
Ophthalmology.
1986;
93
1310-1315
-
57
Niederkorn J Y, Alizadeh H, Leher H et al.
The pathogenesis of Acanthamoeba keratitis.
Microbes Infect.
1999;
1
437-443
-
58 Holbach L M, Hinzpeter E N, Naumann G O H. Kornea und Sklera.. Naumann G OH, Hrsg. Pathologie des Auges.. Heidelberg: Springer; 1986: 631-632
-
59
Herz N L, Matoba A Y, Wilhelmus K R.
Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.
Ophthalmology.
2008;
115
866-869
-
60
Kelley P S, Dossey A P, Patel D et al.
Secondary glaucoma associated with advanced acanthamoeba keratitis.
Eye Contact Lens.
2006;
32
178-182
-
61
Awwad S T, Heilman M, Hogan R N et al.
Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome.
Ophthalmology.
2007;
114
313-320
-
62
Moshari A, McLean I W, Dodds M T et al.
Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature.
Ophthalmology.
2001;
108
2232-2236
-
63
Ebrahimi K B, Green W R, Grebe R et al.
Acanthamoeba sclerokeratitis.
Graefes Arch Clin Exp Ophthalmol.
2009;
247
283-286
-
64
Cavanagh H D, Petroll W M, Alizadeh H et al.
Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease.
Ophthalmology.
1993;
100
1444-1454
-
65
Auran J D, Starr M B, Koester C J et al.
In vivo scanning slit confocal microscopy of Acanthamoeba keratitis. A case report.
Cornea.
1994;
13
183-185
-
66
Pfister D R, Cameron J D, Krachmer J H et al.
Confocal microscopy findings of Acanthamoeba keratitis.
Am J Ophthalmol.
1996;
121
119-128
-
67
Mathers W D, Nelson S E, Lane J L et al.
Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis.
Arch Ophthalmol.
2000;
118
178-183
-
68
Parmar D N, Awwad S T, Petroll W M et al.
Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis.
Ophthalmology.
2006;
113
538-547
-
69
Efron N.
Contact lens-induced changes in the anterior eye as observed in vivo with the confocal microscope.
Prog Retin Eye Res.
2007;
26
398-436
-
70
Mathers W D.
Acanthamoeba: a difficult pathogen to evaluate and treat.
Cornea.
2004;
23
325
-
71
Tu E Y, Joslin C E, Sugar J et al.
The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis.
Cornea.
2008;
27
764-772
-
72
Gray T B, Cursons R T, Sherwan J F et al.
Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases.
Br J Ophthalmol.
1995;
79
601-605
-
73
Larkin D F, Kilvington S, Easty D L.
Contamination of contact lens storage cases by Acanthamoeba and bacteria.
Br J Ophthalmol.
1990;
74
133-135
-
75 Aspöck H. Grundzüge der Diagnostik.. In: Hiepe T, Lucius R, Gottstein B Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung.. Stuttgart: Parey in MVS Medizinverlage; 2006: 477
-
76
Riviere D, Szczebara F M, Berjeaud J M et al.
Development of a real-time PCR assay for quantification of Acanthamoeba trophozoites and cysts.
J Microbiol Methods.
2006;
64
78-83
-
77
Mathers W D, Sutphin J E, Folberg R et al.
Outbreak of keratitis presumed to be caused by Acanthamoeba.
Am J Ophthalmol.
1996;
121
129-142
-
78
Wilhelmus K R, Osato M S, Font R L et al.
Rapid diagnosis of Acanthamoeba keratitis using calcofluor white.
Arch Ophthalmol.
1986;
104
1309-1312
-
79
Duguid I G, Dart J K, Morlet N et al.
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
Ophthalmology.
1997;
104
1587-1592
-
80
Lehmann O J, Green S M, Morlet N et al.
Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis.
Invest Ophthalmol Vis Sci.
1998;
39
1261-1265
-
81
Qvarnstrom Y, Visvesvara G S, Sriram R et al.
Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri.
J Clin Microbiol.
2006;
44
3589-3595
-
82
Thompson P P, Kowalski R P, Shanks R M et al.
Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis.
J Clin Microbiol.
2008;
46
3232-3236
-
83
Bacon A S, Dart J K, Ficker L A et al.
Acanthamoeba keratitis. The value of early diagnosis.
Ophthalmology.
1993;
100
1238-1243
-
84
Tu E Y, Joslin C E, Sugar J et al.
Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
Ophthalmology.
2008;
115
1998-2003
-
85
Brooks jr. J G, Coster D J, Badenoch P R.
Acanthamoeba keratitis. Resolution after epithelial debridement.
Cornea.
1994;
13
186-189
-
86
Holland G N, Donzis P B.
Rapid resolution of early Acanthamoeba keratitis after epithelial debridement.
Am J Ophthalmol.
1987;
104
87-89
-
87
Ishibashi Y, Matsumoto Y, Kabata T et al.
Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis.
Am J Ophthalmol.
1990;
109
121-126
-
88
Elder M J, Kilvington S, Dart J K.
A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
Invest Ophthalmol Vis Sci.
1994;
35
1059-1064
-
89
Hay J, Kirkness C M, Seal D V et al.
Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
Eye (Lond).
1994;
8 (Pt 5)
555-563
-
90
Larkin D F, Kilvington S, Dart J K.
Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Ophthalmology.
1992;
99
185-191
-
91
Kaehn K.
Polihexanide: a safe and highly effective biocide.
Skin Pharmacol Physiol.
2010;
23 (Suppl.)
7-16
-
92
Ficker L, Seal D, Warhurst D et al.
Acanthamoeba keratitis – resistance to medical therapy.
Eye (Lond).
1990;
4 (Pt 6)
835-838
-
93
D'Aversa G, Stern G A, Driebe jr. W T.
Diagnosis and successful medical treatment of Acanthamoeba keratitis.
Arch Ophthalmol.
1995;
113
1120-1123
-
94
McClellan K, Howard K, Niederkorn J Y et al.
Effect of steroids on Acanthamoeba cysts and trophozoites.
Invest Ophthalmol Vis Sci.
2001;
42
2885-2893
-
95
Berger S T, Mondino B J, Hoft R H et al.
Successful medical management of Acanthamoeba keratitis.
Am J Ophthalmol.
1990;
110
395-403
-
96
Amoils S P, Heney C.
Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole.
Am J Ophthalmol.
1999;
127
718-720
-
97
Tu E Y, Joslin C E, Shoff M E.
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
Cornea.
2010;
29
1066-1068
-
98
Bang S, Edell E, Eghrari A O et al.
Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
Am J Ophthalmol.
2010;
149
66-69
-
99 Berufsverband der Augenärzte Deutschlands .Leitlinie Nr. 13 Keratitis. 1998
-
100
Lindquist T D.
Treatment of Acanthamoeba keratitis.
Cornea.
1998;
17
11-16
-
101
Murdoch D, Gray T B, Cursons R et al.
Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.
Aust N Z J Ophthalmol.
1998;
26
231-236
-
102
Binder P S.
Cryotherapy for medically unresponsive Acanthamoeba keratitis.
Cornea.
1989;
8
106-114
-
103
Reinhard T, Sundmacher R.
Clinical aspects and therapy of Acanthamoeba keratitis.
Ophthalmologe.
2000;
97
446-459
-
104
Kluppel M, Reinhard T, Sundmacher R et al.
Therapy of advanced amoeba keratitis with keratoplasty a chaud and adjuvant cryotherapy.
Ophthalmologe.
1997;
94
99-103
-
105
Matoba A Y, Pare P D, Le T D et al.
The effects of freezing and antibiotics on the viability of Acanthamoeba cysts.
Arch Ophthalmol.
1989;
107
439-440
-
106
Osato M S, Robinson N M, Wilhelmus K R et al.
In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba.
Rev Infect Dis.
1991;
13 (Suppl. 5)
S431-S435
-
107
Meisler D M, Ludwig I H, Rutherford I et al.
Susceptibility of Acanthamoeba to cryotherapeutic method.
Arch Ophthalmol.
1986;
104
130-131
-
108
Kashiwabuchi R T, de Freitas D, Alvarenga L S et al.
Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis.
Acta Ophthalmol.
2008;
86
666-669
-
109
Sony P, Sharma N, Vajpayee RB et al. Therapeutic keratoplasty for infectious keratitis: a review of the literature.
CLAO J.
2002;
28
111-118
-
110
Ficker L A, Kirkness C, Wright P.
Prognosis for keratoplasty in Acanthamoeba keratitis.
Ophthalmology.
1993;
100
105-110
-
111
Bourcier T, Patteau F, Borderie V et al.
Amniotic membrane transplantation for the treatment severe acanthamoeba keratitis.
Can J Ophthalmol.
2004;
39
621-631
-
112
Hargrave S L, McCulley J P, Husseini Z.
Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.
Ophthalmology.
1999;
106
952-957
-
113
Kitzmann A S, Goins K M, Sutphin J E et al.
Keratoplasty for treatment of Acanthamoeba keratitis.
Ophthalmology.
2009;
116
864-869
-
114
Wermund T K, Wilhelm F, Susskind D et al.
Recurrent Acanthamoeba keratitis in the corneal graft.
Klin Monbl Augenheilkd.
2009;
226
507-509
-
115
Thebpatiphat N, Hammersmith K M, Rocha F N et al.
Acanthamoeba keratitis: a parasite on the rise.
Cornea.
2007;
26
701-706
Dr. Christian Meltendorf, FEBO
Martin-Luther-Universität Halle-Wittenberg
Universitätsklinik und Poliklinik für Augenheilkunde
Ernst-Grube-Straße 40
06120 Halle (Saale)
Telefon: 0345-5571562
Fax: 0345-5571848
eMail: christian.meltendorf@medizin.uni-halle.de
